Xpovio® (selinexor) now approved for the treatment of relapsed/refractory diffuse large b-cell lymphoma, available from onco360

Onco360®, the nation’s largest independent oncology pharmacy, has been selected by karyopharm to be a specialty pharmacy partner for xpovio® (selinexo

KPTI Ratings Summary

KPTI Quant Ranking